Total number of protein in "GO:0016529" GO term: 46
Identifier | UniProt Gene | UniProt Accession | UniProt Name | Chromosome | GO term | Database | Cancer Driver | Number of missense mutations | Missense mutation per residues | Number of disordered residues | Number of mutations in disordered regions | Disordered missense mutations per residues | Number of OMIM mutation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AGL-203 | AGL | P35573 | Glycogen debranching enzyme | chr1 | GO:0016529 | Not Cancer Driver | No | 139 | 0.0907310704960835 | 144 | 17 | 0.0110966057441253 | 1 |
AKAP6-201 | AKAP6 | Q13023 | A-kinase anchor protein 6 | chr14 | GO:0016529 | Not Cancer Driver | No | 295 | 0.1272100043122035 | 1464 | 188 | 0.0810694264769297 | 0 |
ANK1-205 | ANK1 | P16157 | Ankyrin-1 | chr8 | GO:0016529 | Census | Yes | 315 | 0.1674641148325359 | 813 | 131 | 0.0696438064859117 | 3 |
ANK3-201 | ANK3 | Q12955 | Ankyrin-3 | chr10 | GO:0016529 | Not Cancer Driver | No | 652 | 0.1489604752113319 | 3069 | 442 | 0.1009824080420379 | 0 |
ATP2A1-201 | ATP2A1 | O14983 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | chr16 | GO:0016529 | Not Cancer Driver | No | 125 | 0.1248751248751248 | 80 | 9 | 0.0089910089910089 | 1 |
ATP2A2-204 | ATP2A2 | P16615 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | chr12 | GO:0016529 | Not Cancer Driver | No | 106 | 0.1017274472168906 | 78 | 13 | 0.0124760076775431 | 40 |
ATP2A3-205 | ATP2A3 | Q93084 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 | chr17 | GO:0016529 | Not Cancer Driver | No | 92 | 0.0920920920920921 | 147 | 13 | 0.013013013013013 | 0 |
CACNA1S-201 | CACNA1S | Q13698 | Voltage-dependent L-type calcium channel subunit alpha-1S | chr1 | GO:0016529 | Not Cancer Driver | No | 287 | 0.1532301121195942 | 386 | 60 | 0.0320341697810998 | 4 |
CACNA2D1-203 | CACNA2D1 | P54289 | Voltage-dependent calcium channel subunit alpha-2/delta-1 | chr7 | GO:0016529 | Not Cancer Driver | No | 221 | 0.2003626473254759 | 99 | 21 | 0.0190389845874886 | 1 |
CASQ1-201 | CASQ1 | P31415 | Calsequestrin-1 | chr1 | GO:0016529 | Not Cancer Driver | No | 61 | 0.154040404040404 | 110 | 15 | 0.0378787878787878 | 4 |
CASQ2-201 | CASQ2 | O14958 | Calsequestrin-2 | chr1 | GO:0016529 | Not Cancer Driver | No | 49 | 0.1228070175438596 | 76 | 8 | 0.0200501253132832 | 4 |
CCDC78-201 | CCDC78 | A2IDD5 | Coiled-coil domain-containing protein 78 | chr16 | GO:0016529 | Not Cancer Driver | No | 33 | 0.0753424657534246 | 310 | 22 | 0.0502283105022831 | 0 |
CLEC18B-201 | CLEC18B | Q6UXF7 | C-type lectin domain family 18 member B | chr16 | GO:0016529 | Not Cancer Driver | No | 54 | 0.1186813186813186 | 10 | 0 | 0.0 | 0 |
CMYA5-201 | CMYA5 | Q8N3K9 | Cardiomyopathy-associated protein 5 | chr5 | GO:0016529 | Not Cancer Driver | No | 449 | 0.1103465224870975 | 3434 | 388 | 0.0953551241091177 | 0 |
COL6A1-201 | COL6A1 | P12109 | Collagen alpha-1(VI) chain | chr21 | GO:0016529 | Not Cancer Driver | No | 68 | 0.0661478599221789 | 436 | 23 | 0.0223735408560311 | 12 |
FKBP1A-204 | FKBP1A | P62942 | Peptidyl-prolyl cis-trans isomerase FKBP1A | chr20 | GO:0016529 | Not Cancer Driver | No | 11 | 0.1018518518518518 | 39 | 6 | 0.0555555555555555 | 0 |
FSD2-201 | FSD2 | A1L4K1 | Fibronectin type III and SPRY domain-containing protein 2 | chr15 | GO:0016529 | Not Cancer Driver | No | 82 | 0.1094793057409879 | 300 | 45 | 0.0600801068090787 | 0 |
GSTM2-201 | GSTM2 | P28161 | Glutathione S-transferase Mu 2 | chr1 | GO:0016529 | Not Cancer Driver | No | 16 | 0.073394495412844 | 5 | 0 | 0.0 | 0 |
HAX1-201 | HAX1 | O00165 | HCLS1-associated protein X-1 | chr1 | GO:0016529 | Not Cancer Driver | No | 30 | 0.1075268817204301 | 219 | 23 | 0.082437275985663 | 2 |
HK2-201 | HK2 | P52789 | Hexokinase-2 | chr2 | GO:0016529 | Not Cancer Driver | No | 108 | 0.1177753544165757 | 78 | 2 | 0.0021810250817884 | 0 |
IRAG1-208 | IRAG1 | Q9Y6F6 | Inositol 1,4,5-triphosphate receptor associated 1 | chr11 | GO:0016529 | Not Cancer Driver | No | 108 | 0.1194690265486725 | 795 | 98 | 0.1084070796460177 | 0 |
ITPR1-237 | ITPR1 | Q14643 | Inositol 1,4,5-trisphosphate receptor type 1 | chr3 | GO:0016529 | Not Cancer Driver | No | 272 | 0.0986221899927483 | 581 | 56 | 0.0203045685279187 | 6 |
ITPR2-202 | ITPR2 | Q14571 | Inositol 1,4,5-trisphosphate receptor type 2 | chr12 | GO:0016529 | Not Cancer Driver | No | 260 | 0.0962606442058496 | 398 | 46 | 0.0170307293594964 | 1 |
ITPR3-202 | ITPR3 | Q14573 | Inositol 1,4,5-trisphosphate receptor type 3 | chr6 | GO:0016529 | Not Cancer Driver | No | 260 | 0.0973418195432422 | 385 | 31 | 0.0116061400224634 | 2 |
JPH1-201 | JPH1 | Q9HDC5 | Junctophilin-1 | chr8 | GO:0016529 | Not Cancer Driver | No | 102 | 0.1543116490166414 | 422 | 67 | 0.1013615733736762 | 0 |
JPH2-202 | JPH2 | Q9BR39 | Junctophilin-2 | chr20 | GO:0016529 | Not Cancer Driver | No | 107 | 0.153735632183908 | 545 | 75 | 0.1077586206896551 | 6 |
JSRP1-201 | JSRP1 | Q96MG2 | Junctional sarcoplasmic reticulum protein 1 | chr19 | GO:0016529 | Not Cancer Driver | No | 38 | 0.1148036253776435 | 320 | 39 | 0.1178247734138972 | 0 |
MTMR12-203 | MTMR12 | Q9C0I1 | Myotubularin-related protein 12 | chr5 | GO:0016529 | Not Cancer Driver | No | 71 | 0.0950468540829986 | 131 | 8 | 0.0107095046854083 | 0 |
NOL3-205 | NOL3 | O60936 | Nucleolar protein 3 | chr16 | GO:0016529 | Not Cancer Driver | No | 7 | 0.0336538461538461 | 179 | 5 | 0.0240384615384615 | 2 |
NOS1-201 | NOS1 | P29475 | Nitric oxide synthase 1 | chr12 | GO:0016529 | Not Cancer Driver | No | 329 | 0.2294281729428172 | 342 | 84 | 0.0585774058577405 | 0 |
P3H2-201 | P3H2 | Q8IVL5 | Prolyl 3-hydroxylase 2 | chr3 | GO:0016529 | Not Cancer Driver | No | 100 | 0.1412429378531073 | 160 | 21 | 0.0296610169491525 | 1 |
PLN-201 | PLN | P26678 | Cardiac phospholamban | chr6 | GO:0016529 | Not Cancer Driver | No | 5 | 0.0961538461538461 | 0 | 0 | 0.0 | 1 |
POMT1-203 | POMT1 | Q9Y6A1 | Protein O-mannosyl-transferase 1 | chr9 | GO:0016529 | Not Cancer Driver | No | 47 | 0.0629183400267737 | 55 | 3 | 0.0040160642570281 | 9 |
RASD1-201 | RASD1 | Q9Y272 | Dexamethasone-induced Ras-related protein 1 | chr17 | GO:0016529 | Not Cancer Driver | No | 15 | 0.0533807829181494 | 40 | 1 | 0.0035587188612099 | 0 |
RYR1-202 | RYR1 | P21817 | Ryanodine receptor 1 | chr19 | GO:0016529 | Not Cancer Driver | No | 741 | 0.1470821754664549 | 1198 | 186 | 0.0369194124652639 | 139 |
RYR2-201 | RYR2 | Q92736 | Ryanodine receptor 2 | chr1 | GO:0016529 | Not Cancer Driver | No | 1443 | 0.2905174149385947 | 784 | 227 | 0.045701630763036 | 52 |
S100A1-201 | S100A1 | P23297 | Protein S100-A1 | chr1 | GO:0016529 | Not Cancer Driver | No | 10 | 0.1063829787234042 | 9 | 0 | 0.0 | 0 |
SGCD-202 | SGCD | Q92629 | Delta-sarcoglycan | chr5 | GO:0016529 | Not Cancer Driver | No | 56 | 0.1937716262975778 | 74 | 16 | 0.0553633217993079 | 2 |
SLC2A4-201 | SLC2A4 | P14672 | Solute carrier family 2, facilitated glucose transporter member 4 | chr17 | GO:0016529 | Not Cancer Driver | No | 47 | 0.0923379174852652 | 44 | 6 | 0.0117878192534381 | 1 |
SLN-201 | SLN | O00631 | Sarcolipin | chr11 | GO:0016529 | Not Cancer Driver | No | 7 | 0.2258064516129032 | 0 | 0 | 0.0 | 0 |
SRI-201 | SRI | P30626 | Sorcin | chr7 | GO:0016529 | Not Cancer Driver | No | 8 | 0.0404040404040404 | 32 | 0 | 0.0 | 0 |
SYNE2-202 | SYNE2 | Q8WXH0 | Nesprin-2 | chr14 | GO:0016529 | Not Cancer Driver | No | 580 | 0.0842411038489469 | 1900 | 180 | 0.0261437908496732 | 1 |
THBS1-201 | THBS1 | P07996 | Thrombospondin-1 | chr15 | GO:0016529 | Not Cancer Driver | No | 153 | 0.1307692307692307 | 321 | 50 | 0.0427350427350427 | 0 |
THBS4-201 | THBS4 | P35443 | Thrombospondin-4 | chr5 | GO:0016529 | Not Cancer Driver | No | 99 | 0.1030176899063475 | 282 | 33 | 0.0343392299687825 | 0 |
TRDN-201 | TRDN | Q13061 | Triadin | chr6 | GO:0016529 | Not Cancer Driver | No | 59 | 0.0809327846364883 | 646 | 55 | 0.0754458161865569 | 1 |
XDH-201 | XDH | P47989 | Xanthine dehydrogenase/oxidase | chr2 | GO:0016529 | Not Cancer Driver | No | 227 | 0.1702925731432858 | 136 | 20 | 0.0150037509377344 | 1 |